
    
      This is a follow-up protocol to prospectively monitor pregnancy, delivery, and neonatal
      outcomes of women who were treated with corifollitropin alfa and became pregnant after fresh
      embryo transfer during the base study P05714 (NCT00696878). For this trial, no study specific
      assessments are required, but information as obtained in standard practice will be used.
    
  